The commonly used treatments of stroke in clinic include tissue plasminogen activator thrombolytic therapy and thrombus clearance surgery, but both are limited by inability to repair damaged neural circuits, and only 10% of stroke patients meet the treatment standards (Fugate and Rabinstein, 2015; Nagaraja et al., 2020). Here, PLAT is linked to stroke disorder.